tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
US Market

Inhibikase Therapeutics (IKT) Balance Sheet

Compare
172 Followers

Inhibikase Therapeutics Balance Sheet

Inhibikase Therapeutics's total assets for Q3 2025 were $79.59M, a decrease of -10.42% from the previous quarter. IKT total liabilities were $6.70M for the fiscal quarter, a -23.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 98.60M$ 14.51M$ 24.94M$ 42.47M$ 14.78M
Total Liabilities
$ 3.73M$ 3.53M$ 3.90M$ 4.05M$ 5.00M
Total Equity Gross Minority
$ 94.87M$ 10.98M$ 21.04M$ 38.42M$ 9.78M
Other Metrics
Currency in USD

Inhibikase Therapeutics Debt to Assets